Participation of liver fractions and of intestinal bacteria in the metabolism of N-hydroxy-N-2-fluorenylacetamide in the rat.
D000085:Acetates / Q000378:metabolism; D000367:Age Factors; D000577:Amides / Q000378:metabolism*; D000818:Animals; D002273:Carcinogens / Q000378:metabolism*; D002432:Cecum / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism / Q000382:microbiology; D003090:Coliphages / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology; D005965:Glucuronates / Q000378:metabolism; D005966:Glucuronidase / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009355:Neomycin / Q000494:pharmacology; D010084:Oxidation-Reduction; D014677:Pharmaceutical Vehicles; D051381:Rats; D012737:Sex Factors; D013045:Species Specificity
D000085:Acetates; D000577:Amides; D002273:Carcinogens; D005965:Glucuronates; D014677:Pharmaceutical Vehicles; D006899:Mixed Function Oxygenases; D005966:Glucuronidase; D009355:Neomycin